Whether a similar requirement for the United States will also end this month is not known
FDA Admits Flaws in Response to Infant Formula Shortage
Problems highlighted in report include outdated data-sharing systems, below-normal staffing and training for food inspectors
Sudan Ebola Outbreak Declared in Africa
The World Health Organization (WHO) announced today the Uganda Virus Research Institute confirmed a Sudan ebolavirus case after testing a sample taken from a 24-year-old male in Mubende district in the central part of the country.
The confirmation on September 20, 2022, follows an investigation by the National Rapid Response team of six suspicious deaths in the district in September 2022.
Furthermore, the WHO stated eight suspected cases are receiving care in a health facility.
Uganda last reported a Sudan ebolavirus outbreak in 2012.
Who Says Staff Doesn't Need Monkeypox Vaccinations
The U.S. Department of Health and Human Services' Administration for Strategic Preparedness and Response (ASPR) recently confirmed it is making a total of 1.1 million vials of Bavarian Nordic's Jynneos® vaccine available to jurisdictions in the USA to support monkeypox response efforts.
As of September 14, 2022, ASPR had released 807,093 vials to all jurisdictions for free.
These Jynneos vaccines support the 23,893 confirmed monkeypox/orthopoxvirus cases in the USA as of September 19, 2022.
Bebtelovimab Appears Reliable for COVID-19 During Omicron Epoch
Patients receiving bebtelovimab have more comorbidities, but do not have increased rates of progression to severe disease
Will Europe Lead RSV Prevention
Recent news out of Paris indicates a much anticipated Respiratory Syncytial Virus (RSV) prevention treatment for children may soon gain European regulator approval. Moreover, this innovative vaccine-like RSV treatment could become a financial blockbuster.
Will Europe Lead in RSV Prevention
Recent news out of Paris indicates a much anticipated Respiratory Syncytial Virus (RSV) prevention treatment for children may soon gain European regulator approval. Moreover, this innovative vaccine-like RSV treatment could become a financial blockbuster.
Long-Ebola Needs Extensive Research
Lingering symptoms have been reported by Ebola virus disease (EVD) survivors in Africa over the past few years.
For example, the Liberian Ebola Survivors Cohort study published on September 6, 2022, found headache, fatigue, joint pain, muscle pain, hearing loss, visual loss, and numbness of hands or feet were longitudinally assessed among EVD participants.
At baseline, about 75% reported at least one symptom, and 85% significantly interfered with life.
Telehealth Services Use for Opioid Use Disorder Rose During Pandemic
More Medicare beneficiaries received OUD-related telehealth services, behavioral health-related telehealth services, meds for OUD
Full-Dose Anticoagulation Beneficial for Critically Ill With COVID-19
However, no significant difference seen in efficacy or safety outcomes for clopidogrel versus no antiplatelet therapy